Skip to main content

Advertisement

Table 1 Patient characteristics

From: A retrospective analysis of patient-specific factors on voriconazole clearance

  Mean (SD)
Male/Female 50/13
Age (yr) 70.8 (11.0)
Body Weight (kg) 49.7 (9.5)
Body Mass Index (kg/m2) 19.0 (2.9)
Albumin (g/dl)a 2.7 (0.7)
Creatinine clearance (ml/min)a 67.4 (31.9)
AST (IU/L)a 32.9 (28.6)
ALT (IU/L)a 32.9 (35.9)
ALP (IU/L)a 386.6 (409.2)
γGTP (IU/L)a 103.7 (173.1)
T-Bil (mg/dl)a 0.6 (0.8)
C reactive protein (mg/dl)a 5.6 (6.4)
Daily dose (mg/day)a 273 (89.8)
Trough concentration (μg/ml)a 3.2 (2.3)
Trough concentration collection date (after initial dose)a  
 with loading dose 9.7 (13)
 without loading dose 11.1 (9.5)
Purpose of voriconazole administration prophylaxis/treatment 3/60
Diagnosis and treatment department  
 Hematology/Pulmonology/Rheumatology/Other 41/17/4/1
Concomitant medicationa  
 Glucocorcicoid 28
 Macrolide Antibiotics 2
  1. aA cumulative total of 77 samples
  2. These data were collected at the time of initial voriconazole administration